{name}
{subtitle}
Sasanlimab (PF-06801591) in Combination With BCG or as Single Agent in Participants With High-Risk Non-Muscle Invasive Bladder Cancer
city
~14 mi. (Torino, Italy, +153 more cities)
facility
AO Azienda Ospedaliera Ordine Mauriziano Di Torino
condition
Bladder Urothelial Carcinoma, +2 more conditions
drug
BCG solution, +1 more drug
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
city
~14 mi. (Torino, Italy, +170 more cities)
facility
Novartis Investigative Site
biomarker
ER Negative, +4 more biomarkers
drug
alpelisib, +1 more drug
drug type
chemotherapy, +1 more type
Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma
city
~14 mi. (Torino, Italy, +12 more cities)
facility
AOU Citta della Salute e della Scienza- Presidio Ospedaliero Infantile Regina Margherita
biomarker
BRAF V600E, +1 more biomarker
condition
Cutaneous Melanoma, +2 more conditions
drug
binimetinib, +1 more drug
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~17 mi. (Cona, Italy, +142 more cities)
facility
Arcispedale S.Anna - Ematologi
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug
Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH
city
~23 mi. (Ferrara, Italy, +122 more cities)
facility
A.O.U. di Ferrara
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
city
~35 mi. (Ravenna, Italy, +141 more cities)
facility
GSK Investigational Site
drug type
chemotherapy, +1 more type